Cue Biopharma plans a major share consolidation on Nasdaq, signaling a strategic shift in structure and market positioning.
Nasdaq: ABVC BioPharma Highlights Safety Profile of Its Plant-Based ADHD Candidate Amid Growing Concerns About Psychiatric Polypharmacy in the United States
SILICON VALLEY, CA - (NEWMEDIAWIRE) - ABVC BioPharma, Inc. ("ABVC" or the "Company") (NASDAQ: ABVC) today addressed recent public discussions ...
ABVC BioPharma Highlights Safety Profile of Its Plant-Based ADHD Candidate Amid Growing Concerns About Psychiatric Polypharmacy in the United States
Yahoo Finance: GC Biopharma Announces Presentation on Aggregation Profiles of Commercial IVIG Products at NHIA 2026
GC Biopharma Announces Presentation on Aggregation Profiles of Commercial IVIG Products at NHIA 2026
Nasdaq: Immix Biopharma Reports Class-Leading Safety Profile for CAR-T NXC-201 in Low-Volume AL Amyloidosis, On Track for BLA Submission
Immix Biopharma Reports Class-Leading Safety Profile for CAR-T NXC-201 in Low-Volume AL Amyloidosis, On Track for BLA Submission
Finding the right people for critical open roles can be difficult even for biopharma leaders. In this column, Kaye/Bassman’s Michael Pietrack discusses four pitfalls executives face during the hiring ...
Kosmo: GC Biopharma Enhances IVIG Safety Profile with Advanced Prothrombotic Impurity Detection Technology
GC Biopharma Enhances IVIG Safety Profile with Advanced Prothrombotic Impurity Detection Technology
Benzinga on MSN: Cue Biopharma receives $7.5M milestone payment from Boehringer Ingelheim
Cue Biopharma Inc. CUE announced it will receive a $7.5 million preclinical milestone payment from Boehringer Ingelheim. The biopharmaceutical company is developing injectable biologics to selectively ...
ETF Daily News: Northern Trust Corp Grows Stock Holdings in Benitec Biopharma Inc. (NASDAQ:BNTC)